<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sisli Etfal Hastan Tip Bul</journal-id><journal-id journal-id-type="iso-abbrev">Sisli Etfal Hastan Tip Bul</journal-id><journal-id journal-id-type="pmc-domain-id">3841</journal-id><journal-id journal-id-type="pmc-domain">sehtb</journal-id><journal-id journal-id-type="publisher-id">Med Bull Sisli Etfal Hosp</journal-id><journal-title-group><journal-title>The Medical Bulletin of Sisli Etfal Hospital</journal-title></journal-title-group><issn pub-type="ppub">1302-7123</issn><issn pub-type="epub">1308-5123</issn><publisher><publisher-name>University of Health Sciences, S&#807;is&#807;li Hamidye Etfal Training and Research Hospital</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11983023</article-id><article-id pub-id-type="pmcid-ver">PMC11983023.1</article-id><article-id pub-id-type="pmcaid">11983023</article-id><article-id pub-id-type="pmcaiid">11983023</article-id><article-id pub-id-type="pmid">40226565</article-id><article-id pub-id-type="doi">10.14744/SEMB.2024.40374</article-id><article-id pub-id-type="publisher-id">SEMB-59-028</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Evaluation of the Psychosocial Burden of Hidradenitis Suppurativa and Relevant Factors: A Prospective Single-Center Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Altunay</surname><given-names initials="IK">Ilknur Kivanc</given-names></name><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-1354-7123" ext-link-type="uri">https://orcid.org/0000-0002-1354-7123</ext-link><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Tekin</surname><given-names initials="CA">Cemre Akpulat</given-names></name><xref rid="cor1" ref-type="corresp"/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-0024-6735" ext-link-type="uri">https://orcid.org/0000-0002-0024-6735</ext-link><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aptoula</surname><given-names initials="SI">Sena Inal</given-names></name><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0001-8840-4015" ext-link-type="uri">https://orcid.org/0000-0001-8840-4015</ext-link><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aksu</surname><given-names initials="A">Asli</given-names></name><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0003-3979-7486" ext-link-type="uri">https://orcid.org/0000-0003-3979-7486</ext-link><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kurt</surname><given-names initials="BO">Birgul Ozkesici</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0003-3121-5816" ext-link-type="uri">https://orcid.org/0000-0003-3121-5816</ext-link></contrib><aff id="aff1"><label>1</label>Department of Dermatology, University of Health Sciences T&#252;rkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, T&#252;rkiye</aff><aff id="aff2"><label>2</label>Department of Dermatology, University of Health Sciences T&#252;rkiye, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, T&#252;rkiye</aff></contrib-group><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Cemre Akpulat Tekin, MD. Department of Dermatology, University of Health Sciences T&#252;rkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, T&#252;rkiye <bold>Phone:</bold> +90 505 469 86 03 <bold>E-mail:</bold><email>cemreakpulat97@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>18</day><month>3</month><year>2025</year></pub-date><volume>59</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">486374</issue-id><fpage>28</fpage><lpage>34</lpage><history><date date-type="received"><day>27</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>20</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>19</day><month>12</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>18</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>11</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-14 15:25:24.087"><day>14</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; Copyright 2025 by The Medical Bulletin of Sisli Etfal Hospital</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)</ext-link></license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="SEMB-59-028.pdf"/><abstract><sec id="st1"><title>Objectives</title><p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder in which patients with HS experience profound deterioration in their overall well-being, psychological state and quality of life. This study aimed to evaluate the psychological impact of HS and examined its associations with relevant factors, including sociodemographic and disease-related characteristics.</p></sec><sec id="st2"><title>Methods</title><p>A prospective, single-center study was conducted involving 80 patients with HS. The demographic and clinical characteristics of patients were recorded. Depression Anxiety Stress Scale-21 (DASS-21), Dermatology Life Quality Index (DLQI), and General Health Questionnaire-12 (GHQ-12) were used to assess the psychosocial impact of HS.</p></sec><sec id="st3"><title>Results</title><p>A significant proportion of patients with HS had severe and extremely severe scores in depression, anxiety and stress, with 48.75%, 52.5%, and 48.75% of patients, respectively. Sixty percent of the patients exhibited high psychological disorders while 53.8% experienced severe impairment in their quality of life (QoL). Sociodemographic and clinical factors were evaluated for associations with the scales used in this study. DASS-21 Anxiety (DASS-21A) was significantly positively correlated with lower education levels and higher body mass index (BMI) (p&lt;0.05). There were no significant correlations between the Hurley stages and the other three scales, except for the DASS-21 Stress (DASS-21S) subscale. Patients with a family history had higher DASS-21A, DASS-21 Depression (DASS-21D), DASS-21S, and GHQ-12 (both Likert and traditional scoring) scores compared to those without a family history (p&lt;0.05). Additionally, a positive family history significantly predicted higher scores on DASS-21A, DASS-21D, and DASS-21S (p=0.002; p=0.019; p=0.022, respectively).</p></sec><sec id="st4"><title>Conclusion</title><p>Our findings confirm that a significant proportion of patients with HS had high or extremely high levels on all three scales assessing the psychological burden of HS. Patients were negatively affected psychologically at each Hurley stage. Family history proved to be a strong predictive factor contributing to impaired psychosocial status among individuals with HS. Thus, dermatologists should provide extra care, especially for those with family members affected by this condition.</p></sec></abstract><kwd-group><kwd>Anxiety</kwd><kwd>depression</kwd><kwd>Hidradenitis suppurativa</kwd><kwd>stress</kwd><kwd>sociodemographic</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Hidradenitis suppurativa (HS) is a chronic and systemic inflammatory disorder characterized by painful, deep-seated, inflamed nodules, abscesses, sinus tracts, and scars. Women are more frequently affected by this condition compared to men. Environmental and behavioral factors such as smoking, obesity, sweating, and friction have been suggested to trigger or exacerbate HS on a genetic background.<sup>[<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>]</sup> Research has demonstrated that the chronic nature of the disease with unpredictable flare-ups, besides physical disability associated with intense pain, malodor, discharge, and itch can greatly impact an individual&#8217;s daily life and contribute to psychosocial distress encompassing a range of emotional and social difficulties.<sup>[<xref rid="ref3" ref-type="bibr">3</xref>&#8211;<xref rid="ref5" ref-type="bibr">5</xref>]</sup> It is not surprising that depression, anxiety, and impaired quality of life (QoL) are commonly present among adults with HS, given the nature of the disease.<sup>[<xref rid="ref6" ref-type="bibr">6</xref>]</sup> A recent systematic review including 58 eligible studies highlighted a strong negative impact on patients&#8217; lives based on symptoms, gender disparities, and disease severity.<sup>[<xref rid="ref7" ref-type="bibr">7</xref>]</sup> Furthermore, cultural and regional discrepancies may be important, as reported by a recent investigation conducted in Singapore.<sup>[<xref rid="ref8" ref-type="bibr">8</xref>]</sup></p><p>More studies are needed on the factors that may be effective in this psychosocial impact. Our study aimed to provide further insight into how the mental health of patients with HS was affected within the Turkish population and to evaluate the influence of sociodemographic factors and disease characteristics on the psychological impact.</p><sec sec-type="methods" id="S1"><title>Methods</title><sec id="S1_1"><title>Participants and Protocol</title><p>Eighty patients aged between 18 and 85 years, admitted to our Dermatology and Venereology outpatient clinic from March 2022 to September 2023 and diagnosed with HS, agreed to participate in this prospective, single-center study. Diagnosis of HS was based on three criteria: typical lesions (deep-seated painful nodules), typical anatomical predilection (axillae, groins, perineal and perianal regions, buttocks, infra-mammary and inter-mammary folds), and chronicity and recurrence of lesions.<sup>[<xref rid="ref9" ref-type="bibr">9</xref>]</sup> After recording sociodemographic data, the researcher asked all participants to complete study questionnaires.</p><p>Data including socio-demographic information, clinical features of HS, comorbidities, smoking, alcohol, and substance use were recorded. Hurley staging was used to assess the severity of HS, with patients categorized into three stages based on the Hurley classification.<sup>[<xref rid="ref10" ref-type="bibr">10</xref>]</sup> Informed consent was obtained from all participants, and the study was conducted in accordance with the principles of the latest version of the Helsinki Declaration. Ethical approval for the research was received from the local ethics committee (date: 08.03.2022, decision no: 2005).</p></sec><sec id="S1_2"><title>Scales</title><p>The QoL of the patients was assessed using the Dermatology Life Quality Index (DLQI), which was developed by Finlay and Khan<sup>[<xref rid="ref11" ref-type="bibr">11</xref>]</sup> and has been validated in Turkish.<sup>[<xref rid="ref12" ref-type="bibr">12</xref>]</sup> DLQI scores of 10 and above were considered severe impairment in QoL.<sup>[<xref rid="ref13" ref-type="bibr">13</xref>]</sup> Depression, anxiety, and stress levels were evaluated with the Depression Anxiety Stress Scale-21 (DASS-21), which includes three subdimensions: depression (D), anxiety (A), and stress (S). The DASS-21, which was conducted by Henry and Crawford<sup>[<xref rid="ref14" ref-type="bibr">14</xref>]</sup> in 2005, is the short form of the 42-item scale<sup>[<xref rid="ref15" ref-type="bibr">15</xref>]</sup> and has been validated in Turkish.<sup>[<xref rid="ref16" ref-type="bibr">16</xref>]</sup> The General Health Questionnaire-12 (GHQ-12), which consists of 12 items and was developed by Goldberg and Hillier<sup>[<xref rid="ref17" ref-type="bibr">17</xref>]</sup>, was used to investigate mental well-being. The validity and reliability study of the scale in Turkish was conducted.<sup>[<xref rid="ref18" ref-type="bibr">18</xref>]</sup> Psychological disorder levels were categorized using the GHQ-12 dichotomous scoring method (0-0-1-1), referred to as traditional scoring<sup>[<xref rid="ref19" ref-type="bibr">19</xref>]</sup>, while the Likert scoring method was used in correlation analyses.</p></sec><sec id="S1_3"><title>Statistical Analysis</title><p>SPSS Statistics 15.0 (IBM, Chicago, Illinois, USA) for Windows program was used for statistical analysis. Mann Whitney U test was performed to compare two independent groups in nonparametric values. Kruskal-Wallis test was performed to compare more than two independent groups in nonparametric values. Relationships between numerical variables were examined with Spearman Correlation Analysis if the parametric test condition was not met. p&lt;0.05 was accepted for statistical significance. Linear regression analysis was used to investigate independent factors that impact DASS-21 scores.</p></sec></sec><sec sec-type="results" id="S2"><title>Results</title><p>Eighty patients with HS were included in this study (female, n=30; male, n=50). The mean age of onset of HS was 24.35&#177;8.95 years, and the mean age of the diagnosis was 31.20&#177;10.45 years. Fifteen percent of the patients (n=12) had a family history, and among those with a family history, 58.3% (n=7) had first-degree relatives. The mean body mass index (BMI) of the patients was 29.86&#177;6.14. The axillae (n=65, 81.3%) and inguinal fold (n=38, 47%) were the most frequently involved areas. Two-site involvement was the most common presentation (n=23), and the mean of the total involved sites was 3.06&#177;1.73. Twenty percent of the patients were in Hurley stage I, 46.3% were in stage II, and 32.5% were in stage III. The sociodemographic and clinical characteristics of the patients are presented in <xref rid="T1" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Sociodemographic and clinical characteristics of patients with HS</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Female</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">37.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Male</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">62.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Education</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Uneducated</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Primary school</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">8.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Middle school</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">20.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;High school</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">27.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Junior college and above</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">42.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Marital status</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Single</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">56.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Married</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">43.8</td></tr><tr><td align="left" rowspan="1" colspan="1">HS familial history</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Absent</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">85.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Present</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">15.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Family degree</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;First</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">58.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Second</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">33.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Both first and second</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">8.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking status</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Never smoked</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">17.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Former smoker</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Current smoker</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">80.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Alcohol drinking status</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Never drank</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">57.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Former drinkers</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">17.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Active drinkers</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">25.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Involved area</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Axillae</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">81.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Submammarian fold</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">35.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Gluteal</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">21.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Inside part of thigh</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">32.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Inguinal</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">47.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Pubic</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">21.3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Perianal</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">35.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Vulva/scrotum</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">10.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Other*</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">22.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Total number of affected areas</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;1</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">17.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;2</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">28.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;3</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">20.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;4</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">15.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;5 and above</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">18.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Hurley stage</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;1</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">20.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;2</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">47.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;3</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">32.5</td></tr><tr><td align="left" rowspan="1" colspan="1">HS-related disease/syndrome</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Absent</td><td align="center" rowspan="1" colspan="1">72</td><td align="center" rowspan="1" colspan="1">90.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Follicular occlusion triad</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">8.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Steatocystoma multiplex</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.3</td></tr></tbody></table><table-wrap-foot><fn id="TF1-1"><label>*</label><p>Scalp, face, neck, back, abdomen, atypical; HS: Hidradenitis suppurativa.</p></fn></table-wrap-foot></table-wrap><p>The means of the scales were calculated as follows; DASS-21A: 10.45&#177;10.00, DASS-21D: 13.73&#177;11.19, DASS-21S: 14.38&#177;11.22, DLQI: 12.78&#177;8.73, GHQ-12 (Likert scoring): 14.99&#177;6.53, GHQ-12 (traditional scoring): 4.25&#177;2.95. There were 43 patients (53.8%) with a DLQI score above 10. The percentage of patients with severe and extremely severe scores in DASS-21D, DASS-21A, and DASS-21S was 48.75%, 52.5%, and 48.75%, respectively. GHQ-12 traditional scoring was above 4 points in 60% of patients. Patients were classified according to DASS-21 subscales and GHQ-12 scale cut-off values in <xref rid="T2" ref-type="table">Table 2</xref>.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>Classification of patients according to DASS-21 and GHQ-12 cut-off values</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">DASS-21D</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Normal</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">27.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Mild</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">23.75</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Severe</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">6.25</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Extremely severe</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">42.5</td></tr><tr><td align="left" rowspan="1" colspan="1">DASS-21A</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Normal</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">32.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Mild</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">6.25</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Moderate</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">8.75</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Severe</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Extremely severe</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">47.5</td></tr><tr><td align="left" rowspan="1" colspan="1">DASS-21S</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Normal</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">30</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Mild</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">6.25</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Moderate</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Severe</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">17.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Extremely severe</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">31.25</td></tr><tr><td align="left" rowspan="1" colspan="1">GHQ-12 (traditional scoring)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Low</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;Medium</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;High</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">60</td></tr></tbody></table><table-wrap-foot><fn id="TF2-1"><p>DASS-21: Depression Anxiety Stress Scale-21; DASS-21A: Depression Anxiety Stress Scale-21 Anxiety subscale; DASS-21D: Depression Anxiety Stress Scale-21 Depression subscale; DASS-21S: Depression Anxiety Stress Scale-21 Stress subscale; GHQ-12: General Health Questionnaire-12.</p></fn></table-wrap-foot></table-wrap><p>DLQI, all subscales of DASS-21, and GHQ-12 were evaluated according to gender, age, education, marital status, BMI, disease onset age and age of diagnosis, family history, involvement areas, the total number of involved areas, and Hurley staging. DASS-21A negatively correlated with education level (r=-0.222; p=0.047) and positively with BMI (r=0.260; p=0.020). There were no significant correlations between the Hurley stages and the other three scales except for the DASS-21 stress subscale. DASS-21S was only positively correlated with the Hurley stages (r=0.258; p=0.021). Patients with a family history had higher DASS-21A, DASS-21D, DASS-21S, and GHQ-12 (both Likert and traditional scoring) scores than those without (p=0.004; p=0.007; p=0.017; p=0.025; p=0.043, respectively) (<xref rid="F1" ref-type="fig">Fig. 1</xref>). There was no statistically significant difference in the DLQI mean scores between patients with and without a family history of HS (p&gt;0.05). No statistically significant correlation was found between scales and other parameters, including gender, age, marital status, age at onset and age at diagnosis, areas of involvement, and total number of involved areas (p&gt;0.05). Significant correlation analyses between the variables and the scales are presented in <xref rid="T3" ref-type="table">Table 3</xref>.</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><p>Patients with a family history of HS had higher DASS-21 total, DASS-21A, DASS-21D, DASS-21S, and GHQ-12 (both Likert and traditional scoring) scores than those without.</p><p>DASS-21A: Depression Anxiety Stress Scale-21 Anxiety subscale; DASS-21D: Depression Anxiety Stress Scale-21 Depression subscale; DASS-21S: Depression Anxiety Stress Scale-21 Stress subscale; GHQ-12: General Health Questionnaire-12 (Likert scoring); GHQ-12*: General Health Questionnaire-12 (traditional scoring); DLQI: Dermatology Life Quality Index.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="SEMB-59-028-g001.jpg"/></fig><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><p>Significant correlation analyses between variables and scales</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"/><th colspan="2" align="center" rowspan="1">DASS-A</th><th colspan="2" align="center" rowspan="1">DASS-D</th><th colspan="2" align="center" rowspan="1">DASS-S</th><th colspan="2" align="center" rowspan="1">DLQI</th><th colspan="2" align="center" rowspan="1">GHQ</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">r</th><th align="center" rowspan="1" colspan="1">p</th><th align="center" rowspan="1" colspan="1">r</th><th align="center" rowspan="1" colspan="1">p</th><th align="center" rowspan="1" colspan="1">r</th><th align="center" rowspan="1" colspan="1">p</th><th align="center" rowspan="1" colspan="1">r</th><th align="center" rowspan="1" colspan="1">p</th><th align="center" rowspan="1" colspan="1">r</th><th align="center" rowspan="1" colspan="1">p</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Education</td><td align="center" rowspan="1" colspan="1">-0.222</td><td align="center" rowspan="1" colspan="1">0.047</td><td align="center" rowspan="1" colspan="1">-0.098</td><td align="center" rowspan="1" colspan="1">0.385</td><td align="center" rowspan="1" colspan="1">-0.143</td><td align="center" rowspan="1" colspan="1">0.205</td><td align="center" rowspan="1" colspan="1">-0.107</td><td align="center" rowspan="1" colspan="1">0.346</td><td align="center" rowspan="1" colspan="1">-0.008</td><td align="center" rowspan="1" colspan="1">0.945</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">0.260</td><td align="center" rowspan="1" colspan="1">0.020</td><td align="center" rowspan="1" colspan="1">0.075</td><td align="center" rowspan="1" colspan="1">0.508</td><td align="center" rowspan="1" colspan="1">0.191</td><td align="center" rowspan="1" colspan="1">0.090</td><td align="center" rowspan="1" colspan="1">-0.010</td><td align="center" rowspan="1" colspan="1">0.933</td><td align="center" rowspan="1" colspan="1">0.199</td><td align="center" rowspan="1" colspan="1">0.077</td></tr><tr><td align="left" rowspan="1" colspan="1">Hurley staging</td><td align="center" rowspan="1" colspan="1">0.203</td><td align="center" rowspan="1" colspan="1">0.071</td><td align="center" rowspan="1" colspan="1">0.160</td><td align="center" rowspan="1" colspan="1">0.157</td><td align="center" rowspan="1" colspan="1">0.258</td><td align="center" rowspan="1" colspan="1">0.021</td><td align="center" rowspan="1" colspan="1">0.090</td><td align="center" rowspan="1" colspan="1">0.430</td><td align="center" rowspan="1" colspan="1">0.169</td><td align="center" rowspan="1" colspan="1">0.133</td></tr></tbody></table><table-wrap-foot><fn id="TF3-1"><p>DASS-21A: Depression Anxiety Stress Scale-21 Anxiety subscale; DASS-21D: Depression Anxiety Stress Scale-21 Depression subscale; DASS-21S: Depression Anxiety Stress Scale-21 Stress subscale; GHQ-12: General Health Questionnaire-12; DLQI: Dermatology Life Quality Index; BMI: Body Mass Index.</p></fn></table-wrap-foot></table-wrap><p>Sociodemographic and clinical predictive factors potentially leading to high DASS-21 subscale scores were analyzed. Linear regression analysis revealed that positive family history is the most significant predictive variable affecting DASS-21A, DASS-21D, and DASS-21S scores (p=0.002; p=0.019; p=0.022).</p></sec><sec sec-type="discussion" id="S3"><title>Discussion</title><p>Our findings indicated that nearly half of the patients with HS in our study experienced significant psychological impairment. The important result of this study was that patients with a family history of HS showed higher psychological impairment in all subscales of the DASS-21 and GHQ-12. More importantly, a family history of HS was found to be an important predictor of psychological impact among patients with HS.</p><p>Our study stood out from others because we evaluated the stress with depression and anxiety in patients with an alternative measurement tool, the DASS-21 scale. The percentages of our patients with severe and extremely severe scores for depression, anxiety, and stress were 48.75%, 52.5%, and 48.75%, respectively. Depression and anxiety in patients with HS have been evaluated with meta-analyses in the literature.<sup>[<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref21" ref-type="bibr">21</xref>]</sup> Our findings were consistent with the literature about depression and anxiety in HS.<sup>[<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref20" ref-type="bibr">20</xref>]</sup> In a meta-analysis including 27 articles, it was reported that approximately 1 in 4 adults with HS have depression, and 1 in 5 have anxiety.<sup>[<xref rid="ref21" ref-type="bibr">21</xref>]</sup> In our study, these data were found to show a relatively high prevalence in the Turkish population. Herein, sociocultural influences are likely to play a role. The stress factor in patients with HS has not been examined much with a stress-specific questionnaire. In a study that assessed stress in four inflammatory skin diseases (psoriasis, atopic dermatitis, adult acne, and HS) based on a perceived stress scale, it was found that 52.9% of patients with HS had high perceived stress scores.<sup>[<xref rid="ref22" ref-type="bibr">22</xref>]</sup> Similarly, in our study, approximately half of the patients have high emotional stress levels.</p><p>More than half of our patients had a DLQI score above 10, indicating that the disease had a very large and extremely large effect on the patient's dermatologic QoL. Many studies, including a meta-analysis<sup>[<xref rid="ref23" ref-type="bibr">23</xref>]</sup>, have reported impaired QoL in patients with HS, consistent with our findings<sup>[<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref24" ref-type="bibr">24</xref>,<xref rid="ref25" ref-type="bibr">25</xref>]</sup> Moreover, some studies in the literature reported that the impact of HS on QoL is significantly higher than other skin conditions, such as psoriasis and eczema.<sup>[<xref rid="ref26" ref-type="bibr">26</xref>,<xref rid="ref27" ref-type="bibr">27</xref>]</sup></p><p>The findings of this study showed that 60% of the patients had high scores of GHQ-12, in other words, most of the patients had minor nonpsychotic psychiatric disorders. In a previous study conducted on alexithymia and psychological disorders in 90 patients with HS, they found high psychological disorders, which affected 46.1% of the patients.<sup>[<xref rid="ref28" ref-type="bibr">28</xref>]</sup> The lower level of psychological disorders may be due to the rate of Hurley stage III patients comprising only 9% of the sample, which was 32.5% in our study.</p><p>Our findings revealed that gender, age, age at onset, and age at diagnosis were not significantly associated with psychological impact, including QoL, depression, anxiety, stress, and psychological disorder. In the literature, there are variable outcomes of factors related to depression, anxiety, and QoL. Wright et al.<sup>[<xref rid="ref29" ref-type="bibr">29</xref>]</sup> reported that factors associated with depression included female sex and BMI/obesity in adults. In contrast, J&#248;rgensen et al.<sup>[<xref rid="ref30" ref-type="bibr">30</xref>]</sup> found that female sex and obesity were not statistically significantly correlated with depression, which was consistent with our findings. Since men were more dominant than women in our patient sample, there might not be a correlation between female gender and psychological impact. Contrary to our findings, one study found that younger age was associated with impaired QoL<sup>[<xref rid="ref31" ref-type="bibr">31</xref>]</sup>, while another identified younger age as a risk factor for depression.<sup>[<xref rid="ref30" ref-type="bibr">30</xref>]</sup></p><p>Unlike some studies in the literature, our study did not find a significant correlation between psychosocial impact and involvement areas and the total number of involved areas. J&#248;rgensen et al.<sup>[<xref rid="ref31" ref-type="bibr">31</xref>]</sup> found that high overall DLQI scores were associated with the number of anatomical sites involved, axillary, groin, and gluteal localization. Additionally, Ooi et al.<sup>[<xref rid="ref8" ref-type="bibr">8</xref>]</sup> found that inguinal and gluteal involvement was correlated with anxiety/depression as well as inguinal, gluteal, and suprapubic involvements, which were also associated with poorer QoL.</p><p>Based on our analysis, the level of anxiety statistically correlated negatively with education levels. This result could be explained by the fact that patients with higher education levels who were informed about the nature of HS tended to have lower anxiety. Whereas lacking knowledge or fear of the unknown might lead to anxiety. Thus, raising awareness about the disease among patients might also reduce their anxiety levels. Additionally, in our study, BMI/obesity was found to be associated positively with anxiety levels. Despite our findings, Cohn et al.<sup>[<xref rid="ref32" ref-type="bibr">32</xref>]</sup> investigated risk factors for anxiety in patients with HS and found only depression, female gender, and young age as risk factors.</p><p>Ooi et al.<sup>[<xref rid="ref8" ref-type="bibr">8</xref>]</sup> reported that higher disease severity, based on Hurley staging, physician global assessment, and International HS Severity Score, correlated with poorer QoL and higher Hospital Anxiety and Depression Scale scores. Additionally, associations between higher disease severity and decreased QoL were found in other studies.<sup>[<xref rid="ref8" ref-type="bibr">8</xref>,<xref rid="ref31" ref-type="bibr">31</xref>,<xref rid="ref33" ref-type="bibr">33</xref>]</sup> In our study, Hurley stages of patients were not found to be associated with QoL impairment as well as depression and anxiety levels. A study investigating depression in patients with HS, similar to ours, reported that the severity of HS and depression did not appear to be related. It was concluded that even objectively 'mild' HS constituted a severe condition.<sup>[<xref rid="ref34" ref-type="bibr">34</xref>]</sup> Our results may also suggest that negative psychological effects and impairment in QoL might occur in Turkish patients with HS even in the early Hurley stage and that HS also had a great burden on Turkish patients. In this study, only the stress subscale of DASS-21 showed a positive correlation with Hurley staging. This might be the result of the increased noticeability of the disease, treatment failure, and dissatisfaction.</p><p>As a new outcome, patients with a family history of HS had higher levels of depression, anxiety, stress, and psychological disorder than those without in our study. Furthermore, a positive family history was a significant predictor factor for depression, anxiety, and stress. We inferred that patients' awareness of the psychological, physical, and social effects of the disease within their families increased their levels of psychological impact. Witnessing the illness's impact on loved ones could lead to heightened levels of stress, guilt, and concerns about burdening family members. In addition, as a positive family history had a higher risk of early onset HS, a longer duration of the disease might increase psychosocial impact.<sup>[<xref rid="ref35" ref-type="bibr">35</xref>]</sup> However, unlike our result, Schneider-Burrus et al.<sup>[<xref rid="ref36" ref-type="bibr">36</xref>]</sup> found no association between QoL impairment and positive family history in patients with HS.</p><p>Our study had several potential limitations. First of all, we did not include a control group and did not exclude the presence or absence of comorbidities. Another limitation was the generalizability of the results to the entire population since the study was conducted in a single tertiary care hospital and the small number of study samples. Our study's single-center design and relatively small sample size might have influenced the results. Multicenter studies with larger patient populations investigating the psychosocial effects in patients with HS could reveal new findings and guide future clinical practice.</p></sec><sec sec-type="conclusions" id="S4"><title>Conclusion</title><p>In conclusion, there is limited data in the literature assessing stress levels and general mental health/psychological disorders in patients with HS. Our results provide valuable insights into the psychosocial burden of HS in patients. Approximately half of the patients with HS exhibited severe or extremely severe scores on all the scales included in our study. Patients experienced negative psychosocial effects at each Hurley stage, emphasizing the importance of addressing psychosocial aspects throughout HS management. Low education level and high BMI were significantly associated with higher anxiety levels. Additionally, a family history of HS was found to be a predictive factor for the level of psychosocial impairment, and we recommend that physicians give extra attention to these patients.</p></sec></body><back><fn-group><fn id="fn1"><p>Please cite this article as &#8221;Kivanc Altunay I, Akpulat Tekin C, Inal Aptoula S, Aksu A, Ozkesici Kurt B. Evaluation of the Psychosocial Burden of Hidradenitis Suppurativa and Relevant Factors: A Prospective Single-center Study. Med Bull Sisli Etfal Hosp 2025;59(1):28&#8211;34&#8221;.</p></fn></fn-group><sec id="S5"><title>Disclosures</title><sec id="S5_1"><title>Ethics Committee Approval</title><p>The study was approved by the Sisli Hamidiye Etfal Training and Research Hospital Clinical Research Ethics Committee (date: 08.03.2022, no: 2005).</p></sec></sec><sec id="S6"><title>Peer-review</title><p>Externally peer-reviewed.</p></sec><sec sec-type="COI-statement" id="S7"><title>Conflict of Interest</title><p>None declared.</p></sec><sec sec-type="financial-disclosure" id="S8"><title>Funding Statement</title><p>None declared.</p></sec><sec id="S9"><title>Authorship Contributions</title><p>Concept &#8211; I.K.A., B.O.K., A.A., C.A.T., S.I.A.; Design &#8211; I.K.A., B.O.K., A.A., C.A.T., S.I.A.; Supervision&#8211; I.K.A., B.O.K., A.A., C.A.T., S.I.A.; Fundings &#8211;C.A.T., S.I.A.; Materials &#8211; C.A.T., B.O.K.; Data Collection and/or Processing &#8211; C.A.T., B.O.K., I.K.A.; Analysis and/or Interpretation &#8211; C.A.T., B.O.K., I.K.A.; Literature Review &#8211; C.A.T., B.O.K., I.K.A.; Writing &#8211; C.A.T., B.O.K., I.K.A.; Critical Review &#8211;B.O.K., I.K.A.</p></sec><sec id="S10"><title>Use of AI for Writing Assistance</title><p>None declared.</p></sec><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ballard</surname><given-names>K</given-names></name><name name-style="western"><surname>Shuman</surname><given-names>VL</given-names></name></person-group><article-title>Hidradenitis Suppurativa</article-title><source>StatPearls [Internet]</source><year>2025</year><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>YL</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name></person-group><article-title>Hidradenitis suppurativa: an understanding of genetic factors and treatment</article-title><source>Biomedicines</source><year>2024</year><volume>12</volume><fpage>338</fpage><pub-id pub-id-type="doi">10.3390/biomedicines12020338</pub-id><pub-id pub-id-type="pmid">38397941</pub-id><pub-id pub-id-type="pmcid">PMC10886623</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bilgic</surname><given-names>A</given-names></name><name name-style="western"><surname>Fettahl&#305;oglu Karaman</surname><given-names>B</given-names></name><name name-style="western"><surname>Demirseren</surname><given-names>DD</given-names></name><name name-style="western"><surname>C&#305;nar</surname><given-names>L</given-names></name><name name-style="western"><surname>Kacar</surname><given-names>N</given-names></name><name name-style="western"><surname>T&#252;rel Ermertcan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Internalized stigma in hidradenitis suppurativa: a multicenter cross-sectional study</article-title><source>Dermatology</source><year>2023</year><volume>239</volume><fpage>445</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1159/000529194</pub-id><pub-id pub-id-type="pmid">36702103</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>KA</given-names></name><name name-style="western"><surname>Senthilnathan</surname><given-names>A</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>SR</given-names></name><name name-style="western"><surname>Pichardo</surname><given-names>RO</given-names></name></person-group><article-title>Stigmatization, a social perception which may have a debilitating impact on hidradenitis suppurativa patients: an observational study</article-title><source>Arch Dermatol Res</source><year>2022</year><volume>315</volume><fpage>1049</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1007/s00403-022-02412-5</pub-id><pub-id pub-id-type="pmid">36315267</pub-id><pub-id pub-id-type="pmcid">PMC9628443</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matusiak</surname><given-names>&#321;</given-names></name><name name-style="western"><surname>Bieniek</surname><given-names>A</given-names></name><name name-style="western"><surname>Szepietowski</surname><given-names>JC</given-names></name></person-group><article-title>Hidradenitis suppurativa markedly decreases quality of life and professional activity</article-title><source>J Am Acad Dermatol</source><year>2010</year><volume>62</volume><fpage>706</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2009.09.021</pub-id><pub-id pub-id-type="pmid">20227585</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Machado</surname><given-names>MO</given-names></name><name name-style="western"><surname>Stergiopoulos</surname><given-names>V</given-names></name><name name-style="western"><surname>Maes</surname><given-names>M</given-names></name><name name-style="western"><surname>Kurdyak</surname><given-names>PA</given-names></name><name name-style="western"><surname>Lin</surname><given-names>PY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Depression and anxiety in adults with hidradenitis suppurativa</article-title><source>JAMA Dermatol</source><year>2019</year><volume>155</volume><fpage>939</fpage><pub-id pub-id-type="doi">10.1001/jamadermatol.2019.0759</pub-id><pub-id pub-id-type="pmid">31166590</pub-id><pub-id pub-id-type="pmcid">PMC6551580</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimball</surname><given-names>AB</given-names></name><name name-style="western"><surname>Kirby</surname><given-names>J</given-names></name><name name-style="western"><surname>Ingram</surname><given-names>JR</given-names></name><name name-style="western"><surname>Tran</surname><given-names>T</given-names></name><name name-style="western"><surname>Pansar</surname><given-names>I</given-names></name><name name-style="western"><surname>Ciaravino</surname><given-names>V</given-names></name><etal/></person-group><article-title>Burden of hidradenitis suppurativa: a systematic literature review of patient reported outcomes</article-title><source>Dermatol Ther (Heidelb)</source><year>2024</year><volume>14</volume><fpage>83</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/s13555-023-01085-w</pub-id><pub-id pub-id-type="pmid">38183616</pub-id><pub-id pub-id-type="pmcid">PMC10828455</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ooi</surname><given-names>XT</given-names></name><name name-style="western"><surname>Choi</surname><given-names>E</given-names></name><name name-style="western"><surname>Han</surname><given-names>H</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>H</given-names></name><name name-style="western"><surname>Patwardhan</surname><given-names>KR</given-names></name><name name-style="western"><surname>Chandran</surname><given-names>NS</given-names></name></person-group><article-title>The psychosocial burden of hidradenitis suppurativa in Singapore</article-title><source>JAAD Int</source><year>2023</year><volume>10</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.jdin.2022.10.010</pub-id><pub-id pub-id-type="pmid">36691658</pub-id><pub-id pub-id-type="pmcid">PMC9860399</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vekic</surname><given-names>DA</given-names></name><name name-style="western"><surname>Frew</surname><given-names>J</given-names></name><name name-style="western"><surname>Cains</surname><given-names>GD</given-names></name></person-group><article-title>Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1</article-title><source>Aust J Dermatol</source><year>2018</year><volume>59</volume><fpage>267</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1111/ajd.12770</pub-id><pub-id pub-id-type="pmid">29355905</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Hurley</surname><given-names>HJ</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Roenigk</surname><given-names>RK</given-names></name><name name-style="western"><surname>Roenigk</surname><given-names>HK</given-names><suffix>Jr</suffix></name></person-group><article-title>Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach</article-title><source>Dermatologic Surgery</source><year>1989</year><publisher-loc>New York</publisher-loc><publisher-name>Marcel Dekker</publisher-name><fpage>729</fpage><lpage>39</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finlay</surname><given-names>AY</given-names></name><name name-style="western"><surname>Khan</surname><given-names>GK</given-names></name></person-group><article-title>Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use</article-title><source>Clin Exp Dermatol</source><year>1994</year><volume>19</volume><fpage>210</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2230.1994.tb01167.x</pub-id><pub-id pub-id-type="pmid">8033378</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#214;zt&#252;rkcan</surname><given-names>S</given-names></name><name name-style="western"><surname>Ermertcan</surname><given-names>AT</given-names></name><name name-style="western"><surname>Eser</surname><given-names>E</given-names></name><name name-style="western"><surname>Turhan &#350;ahin</surname><given-names>M</given-names></name></person-group><article-title>Cross validation of the Turkish version of dermatology life quality index</article-title><source>Int J Dermatol</source><year>2006</year><volume>45</volume><fpage>1300</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/j.1365-4632.2006.02881.x</pub-id><pub-id pub-id-type="pmid">17076710</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bong</surname><given-names>YB</given-names></name><name name-style="western"><surname>Tan</surname><given-names>LL</given-names></name><name name-style="western"><surname>Lim</surname><given-names>SX</given-names></name><name name-style="western"><surname>Yong</surname><given-names>ASW</given-names></name><name name-style="western"><surname>Ch&#8217;ng</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Determinants of quality of life and psychological status in adults with psoriasis</article-title><source>Arch Dermatol Res</source><year>2018</year><volume>310</volume><fpage>443</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1007/s00403-018-1832-x</pub-id><pub-id pub-id-type="pmid">29687328</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>JD</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>JR</given-names></name></person-group><article-title>The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample</article-title><source>Br J Clin Psychol</source><year>2005</year><volume>44</volume><fpage>227</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1348/014466505X29657</pub-id><pub-id pub-id-type="pmid">16004657</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lovibond</surname><given-names>PF</given-names></name><name name-style="western"><surname>Lovibond</surname><given-names>SH</given-names></name></person-group><article-title>The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories</article-title><source>Behav Res Ther</source><year>1995</year><volume>33</volume><fpage>335</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/0005-7967(94)00075-U</pub-id><pub-id pub-id-type="pmid">7726811</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yilmaz</surname><given-names>O</given-names></name><name name-style="western"><surname>Box</surname><given-names>H</given-names></name><name name-style="western"><surname>Arslan</surname><given-names>A</given-names></name></person-group><article-title>The validity and reliability of Depression Stress and Anxiety Scale (DASS 21) Turkish short form</article-title><source>J Financ Econ Soc Stud</source><year>2017</year><volume>2</volume><fpage>78</fpage><lpage>91</lpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldberg</surname><given-names>DP</given-names></name><name name-style="western"><surname>Hillier</surname><given-names>VF</given-names></name></person-group><article-title>A scaled version of the General Health Questionnaire</article-title><source>Psychol Med</source><year>1979</year><volume>9</volume><fpage>139</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1017/S0033291700021644</pub-id><pub-id pub-id-type="pmid">424481</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilic</surname><given-names>C</given-names></name><name name-style="western"><surname>Rezaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Rezaki</surname><given-names>B</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>I</given-names></name><name name-style="western"><surname>Ozgen</surname><given-names>G</given-names></name><name name-style="western"><surname>Sagduyu</surname><given-names>A</given-names></name><etal/></person-group><article-title>General Health Questionnaire (GHQ12 &amp; GHQ28): psychometric properties and factor structure of the scales in a Turkish primary care sample</article-title><source>Soc Psychiatry Psychiatr Epidemiol</source><year>1997</year><volume>32</volume><fpage>327</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/BF00805437</pub-id><pub-id pub-id-type="pmid">9299926</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piccinelli</surname><given-names>M</given-names></name><name name-style="western"><surname>Bisoffi</surname><given-names>G</given-names></name><name name-style="western"><surname>Bon</surname><given-names>MG</given-names></name><name name-style="western"><surname>Cunico</surname><given-names>L</given-names></name><name name-style="western"><surname>Tansella</surname><given-names>M</given-names></name></person-group><article-title>Validity and test-retest reliability of the italian version of the 12-item General Health Questionnaire in general practice: a comparison between three scoring methods</article-title><source>Compr Psychiatry</source><year>1993</year><volume>34</volume><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/0010-440X(93)90048-9</pub-id><pub-id pub-id-type="pmid">8339539</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phan</surname><given-names>K</given-names></name><name name-style="western"><surname>Huo</surname><given-names>YR</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SD</given-names></name></person-group><article-title>Hidradenitis suppurativa and psychiatric comorbidities, suicides and substance abuse: systematic review and meta-analysis</article-title><source>Ann Transl Med</source><year>2020</year><volume>8</volume><fpage>821</fpage><pub-id pub-id-type="doi">10.21037/atm-20-1028</pub-id><pub-id pub-id-type="pmid">32793666</pub-id><pub-id pub-id-type="pmcid">PMC7396254</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>KR</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HH</given-names></name><name name-style="western"><surname>Rastogi</surname><given-names>S</given-names></name><name name-style="western"><surname>Vakharia</surname><given-names>PP</given-names></name><name name-style="western"><surname>Hua</surname><given-names>T</given-names></name><name name-style="western"><surname>Chhiba</surname><given-names>K</given-names></name><etal/></person-group><article-title>Association between hidradenitis suppurativa, depression, anxiety, and suicidality: a systematic review and meta-analysis</article-title><source>J Am Acad Dermatol</source><year>2020</year><volume>83</volume><fpage>737</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2019.11.068</pub-id><pub-id pub-id-type="pmid">31862404</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misery</surname><given-names>L</given-names></name><name name-style="western"><surname>Chesnais</surname><given-names>M</given-names></name><name name-style="western"><surname>Merhand</surname><given-names>S</given-names></name><name name-style="western"><surname>Aubert</surname><given-names>R</given-names></name><name name-style="western"><surname>Bru</surname><given-names>MF</given-names></name><name name-style="western"><surname>Legrand</surname><given-names>C</given-names></name><etal/></person-group><article-title>Perceived stress in four inflammatory skin diseases: an analysis of data taken from 7273 adult subjects with acne, atopic dermatitis, psoriasis or hidradenitis suppurativa</article-title><source>J Eur Acad Dermatol Venereol</source><year>2022</year><volume>36</volume><fpage>e623</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/jdv.18016</pub-id><pub-id pub-id-type="pmid">35181931</pub-id><pub-id pub-id-type="pmcid">PMC9546193</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montero-Vilchez</surname><given-names>T</given-names></name><name name-style="western"><surname>Diaz-Calvillo</surname><given-names>P</given-names></name><name name-style="western"><surname>Rodriguez-Pozo</surname><given-names>JA</given-names></name><name name-style="western"><surname>Cuenca-Barrales</surname><given-names>C</given-names></name><name name-style="western"><surname>Martinez-Lopez</surname><given-names>A</given-names></name><name name-style="western"><surname>Arias-Santiago</surname><given-names>S</given-names></name><etal/></person-group><article-title>The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis</article-title><source>Int J Environ Res Public Health</source><year>2021</year><volume>18</volume><fpage>6709</fpage><pub-id pub-id-type="doi">10.3390/ijerph18136709</pub-id><pub-id pub-id-type="pmid">34206415</pub-id><pub-id pub-id-type="pmcid">PMC8293810</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gooderham</surname><given-names>M</given-names></name><name name-style="western"><surname>Papp</surname><given-names>K</given-names></name></person-group><article-title>The psychosocial impact of hidradenitis suppurativa</article-title><source>J Am Acad Dermatol</source><year>2015</year><volume>73</volume><fpage>S19</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2015.07.054</pub-id><pub-id pub-id-type="pmid">26470609</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matusiak</surname><given-names>&#321;</given-names></name></person-group><article-title>Profound consequences of hidradenitis suppurativa: a review</article-title><source>Br J Dermatol</source><year>2020</year><volume>183</volume><fpage>e1719</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/bjd.16603</pub-id><pub-id pub-id-type="pmid">29744872</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matusiak</surname><given-names>&#321;</given-names></name><name name-style="western"><surname>Bieniek</surname><given-names>A</given-names></name><name name-style="western"><surname>Szepietowski</surname><given-names>J</given-names></name></person-group><article-title>Psychophysical aspects of hidradenitis suppurativa</article-title><source>Acta Dermato Venereologica</source><year>2010</year><volume>90</volume><fpage>264</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2340/00015555-0866</pub-id><pub-id pub-id-type="pmid">20526543</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alya</surname><given-names>A</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>A</given-names></name><name name-style="western"><surname>Sawsan</surname><given-names>A</given-names></name><name name-style="western"><surname>Louai</surname><given-names>S</given-names></name></person-group><article-title>Psychosocial implications and quality of life in patients with hidradenitis suppurativa compared to those with atopic dermatitis and psoriasis: a cross-sectional case-control study</article-title><source>Dermatol Pract Concept</source><year>2023</year><volume>13</volume><fpage>e2023076</fpage><pub-id pub-id-type="doi">10.5826/dpc.1302a76</pub-id><pub-id pub-id-type="pmid">37196280</pub-id><pub-id pub-id-type="pmcid">PMC10188164</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinto</surname><given-names>RM</given-names></name><name name-style="western"><surname>Sampogna</surname><given-names>F</given-names></name><name name-style="western"><surname>Fania</surname><given-names>L</given-names></name><name name-style="western"><surname>Ciccone</surname><given-names>D</given-names></name><name name-style="western"><surname>Fusari</surname><given-names>R</given-names></name><name name-style="western"><surname>Mastroeni</surname><given-names>S</given-names></name><etal/></person-group><article-title>Alexithymia, psychological distress, and social impairment in patients with hidradenitis suppurativa</article-title><source>Dermatology</source><year>2021</year><volume>237</volume><fpage>103</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1159/000503319</pub-id><pub-id pub-id-type="pmid">31743903</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wright</surname><given-names>S</given-names></name><name name-style="western"><surname>Strunk</surname><given-names>A</given-names></name><name name-style="western"><surname>Garg</surname><given-names>A</given-names></name></person-group><article-title>New-onset depression among children, adolescents, and adults with hidradenitis suppurativa</article-title><source>J Am Acad Dermatol</source><year>2020</year><volume>83</volume><fpage>1360</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2020.05.090</pub-id><pub-id pub-id-type="pmid">32446831</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>J&#248;rgensen</surname><given-names>AH</given-names></name><name name-style="western"><surname>Holm</surname><given-names>JG</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ring</surname><given-names>HC</given-names></name><name name-style="western"><surname>Thomsen</surname><given-names>SF</given-names></name></person-group><article-title>Occurrence and risk factors of depression in patients with hidradenitis suppurativa</article-title><source>J Am Acad Dermatol</source><year>2020</year><volume>83</volume><fpage>e377</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2020.07.060</pub-id><pub-id pub-id-type="pmid">32707258</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>J&#248;rgensen</surname><given-names>AHR</given-names></name><name name-style="western"><surname>Holm</surname><given-names>JG</given-names></name><name name-style="western"><surname>Ghazanfar</surname><given-names>MN</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ring</surname><given-names>HC</given-names></name><name name-style="western"><surname>Thomsen</surname><given-names>SF</given-names></name></person-group><article-title>Factors affecting quality of life in patients with hidradenitis suppurativa</article-title><source>Arch Dermatol Res</source><year>2020</year><volume>312</volume><fpage>427</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/s00403-019-02025-5</pub-id><pub-id pub-id-type="pmid">31848682</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohn</surname><given-names>E</given-names></name><name name-style="western"><surname>Palma</surname><given-names>G</given-names></name><name name-style="western"><surname>Mastacouris</surname><given-names>N</given-names></name><name name-style="western"><surname>Strunk</surname><given-names>A</given-names></name><name name-style="western"><surname>Garg</surname><given-names>A</given-names></name></person-group><article-title>Incidence of anxiety disorder in adults with hidradenitis suppurativa</article-title><source>Br J Dermatol</source><year>2024</year><volume>191</volume><fpage>351</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1093/bjd/ljae139</pub-id><pub-id pub-id-type="pmid">38564268</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deckers</surname><given-names>IE</given-names></name><name name-style="western"><surname>Kimball</surname><given-names>AB</given-names></name></person-group><article-title>The handicap of hidradenitis suppurativa</article-title><source>Dermatol Clin</source><year>2016</year><volume>34</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.det.2015.07.003</pub-id><pub-id pub-id-type="pmid">26617353</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Senthilnathan</surname><given-names>A</given-names></name><name name-style="western"><surname>Kolli</surname><given-names>SS</given-names></name><name name-style="western"><surname>Cardwell</surname><given-names>LA</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>IM</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>SR</given-names></name><name name-style="western"><surname>Pichardo</surname><given-names>RO</given-names></name></person-group><article-title>Depression in hidradenitis suppurativa</article-title><source>Br J Dermatol</source><year>2019</year><volume>181</volume><fpage>1087</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/bjd.18132</pub-id><pub-id pub-id-type="pmid">31099413</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liy-Wong</surname><given-names>C</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M</given-names></name><name name-style="western"><surname>Kirkorian</surname><given-names>AY</given-names></name><name name-style="western"><surname>Eichenfield</surname><given-names>LF</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>LZ</given-names></name><name name-style="western"><surname>Horev</surname><given-names>A</given-names></name><etal/></person-group><article-title>Hidradenitis suppurativa in the pediatric population</article-title><source>JAMA Dermatol</source><year>2021</year><volume>157</volume><fpage>385</fpage><pub-id pub-id-type="doi">10.1001/jamadermatol.2020.5435</pub-id><pub-id pub-id-type="pmid">33625473</pub-id><pub-id pub-id-type="pmcid">PMC7905696</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider-Burrus</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsaousi</surname><given-names>A</given-names></name><name name-style="western"><surname>Barbus</surname><given-names>S</given-names></name><name name-style="western"><surname>Huss-Marp</surname><given-names>J</given-names></name><name name-style="western"><surname>Witte</surname><given-names>K</given-names></name><name name-style="western"><surname>Wolk</surname><given-names>K</given-names></name><etal/></person-group><article-title>Features associated with quality of life impairment in hidradenitis suppurativa patients</article-title><source>Front Med (Lausanne)</source><year>2021</year><volume>8</volume><fpage>676241</fpage><pub-id pub-id-type="doi">10.3389/fmed.2021.676241</pub-id><pub-id pub-id-type="pmid">33987196</pub-id><pub-id pub-id-type="pmcid">PMC8112201</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>